
| ROI Name | ∑ In  | % In  | log ratio  | ∑ Out  | % Out  | 
|---|---|---|---|---|---|
| PLP_L | 105 | 13.6% | 4.12 | 1,823 | 69.0% | 
| ME_L | 624 | 81.0% | -1.74 | 187 | 7.1% | 
| LH_L | 12 | 1.6% | 4.77 | 327 | 12.4% | 
| MB_CA_L | 10 | 1.3% | 4.91 | 300 | 11.4% | 
| PVLP_L | 12 | 1.6% | -1.26 | 5 | 0.2% | 
| AME_L | 7 | 0.9% | -inf | 0 | 0.0% | 
| upstream partner  | # | NT | conns MTe20  | % In  | CV | 
|---|---|---|---|---|---|
| MeTu2a (L) | 34 | ACh | 206 | 32.9% | 0.5 | 
| MeTu3a (L) | 16 | ACh | 55 | 8.8% | 0.6 | 
| MeMe_e10 (R) | 2 | GABA | 45 | 7.2% | 0.6 | 
| MTe20 (L) | 1 | GABA | 34 | 5.4% | 0.0 | 
| MTe07 (L) | 7 | ACh | 22 | 3.5% | 0.4 | 
| MeTu3b (L) | 15 | ACh | 21 | 3.3% | 0.3 | 
| MeTu2b (L) | 11 | ACh | 17 | 2.7% | 0.4 | 
| DmDRA1 (L) | 9 | Glu | 15 | 2.4% | 0.6 | 
| CB2377 (L) | 1 | ACh | 12 | 1.9% | 0.0 | 
| MTe07 (R) | 4 | ACh | 12 | 1.9% | 0.5 | 
| Sm23 (L) | 7 | GABA | 11 | 1.8% | 0.5 | 
| Sm03 (L) | 10 | Glu | 11 | 1.8% | 0.3 | 
| Mi15 (L) | 9 | Unk | 10 | 1.6% | 0.3 | 
| aMe22 (L) | 1 | Glu | 8 | 1.3% | 0.0 | 
| Sm42 (L) | 1 | GABA | 8 | 1.3% | 0.0 | 
| Sm30 (L) | 6 | GABA | 8 | 1.3% | 0.4 | 
| Sm17 (L) | 4 | GABA | 7 | 1.1% | 0.5 | 
| MeTu3c (L) | 5 | ACh | 7 | 1.1% | 0.3 | 
| CB2377 (R) | 1 | ACh | 6 | 1.0% | 0.0 | 
| MTe06 (L) | 3 | ACh | 6 | 1.0% | 0.7 | 
| aMe19a (R) | 1 | Glu | 5 | 0.8% | 0.0 | 
| s-LNv_a (L) | 1 | 5-HT | 5 | 0.8% | 0.0 | 
| cM11 (L) | 1 | ACh | 5 | 0.8% | 0.0 | 
| CB1744 (L) | 3 | ACh | 5 | 0.8% | 0.6 | 
| Sm18 (L) | 4 | GABA | 5 | 0.8% | 0.3 | 
| Tm4 (L) | 3 | ACh | 4 | 0.6% | 0.4 | 
| cM08b (L) | 1 | Glu | 3 | 0.5% | 0.0 | 
| Sm10 (L) | 3 | GABA | 3 | 0.5% | 0.0 | 
| Dm2 (L) | 3 | ACh | 3 | 0.5% | 0.0 | 
| MTe04 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| DNp27 (L) | 1 | 5-HT | 2 | 0.3% | 0.0 | 
| aMe17a2 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| TmY3 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| MeMe_e09 (R) | 1 | Glu | 2 | 0.3% | 0.0 | 
| DN1a (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| Li20 (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| TmY11 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| Sm34 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| Sm16 (L) | 2 | GABA | 2 | 0.3% | 0.0 | 
| cM03 (R) | 2 | DA | 2 | 0.3% | 0.0 | 
| Mi10 (L) | 2 | ACh | 2 | 0.3% | 0.0 | 
| MLt7 (L) | 2 | ACh | 2 | 0.3% | 0.0 | 
| cM08a (L) | 2 | 5-HT | 2 | 0.3% | 0.0 | 
| aMe4 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| MTe51 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| aMe19b (R) | 1 | GABA | 1 | 0.2% | 0.0 | 
| SMP217 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| MeTu1 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Dm4 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LNd_a (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| AVLP594 (L) | 1 | 5-HT | 1 | 0.2% | 0.0 | 
| Tm32 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| OCG02c (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| aMe6a (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Tm2 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| aMe26 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| aMe9 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| MTe40 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| SMP229 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| Sm14 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| Sm07 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| MeTu4c (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| MeMe_e13 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Tm1 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Mi9 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| FB8B (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| Sm39 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB3735 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Lawf2 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Sm12 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| MeTu4a (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Sm28 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| MTe05 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| Tm27 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| cM08c (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| cL10 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| AVLP533 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB1901 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| MTe01a (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| CB1059 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| Tm5e (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| Sm43 (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| Mi4 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| downstream partner  | # | NT | conns MTe20  | % Out  | CV | 
|---|---|---|---|---|---|
| FB8B (L) | 2 | Glu | 100 | 13.8% | 0.2 | 
| AVLP594 (L) | 1 | 5-HT | 73 | 10.1% | 0.0 | 
| SLP364 (L) | 2 | Glu | 62 | 8.6% | 0.2 | 
| CL356 (L) | 2 | ACh | 49 | 6.8% | 0.1 | 
| aMe13 (R) | 1 | ACh | 45 | 6.2% | 0.0 | 
| MTe06 (L) | 9 | ACh | 45 | 6.2% | 0.5 | 
| MTe20 (L) | 1 | GABA | 34 | 4.7% | 0.0 | 
| AVLP594 (R) | 1 | 5-HT | 25 | 3.5% | 0.0 | 
| SLP368 (L) | 1 | ACh | 22 | 3.0% | 0.0 | 
| SMP229 (L) | 4 | Unk | 22 | 3.0% | 1.1 | 
| SMP529 (L) | 1 | ACh | 20 | 2.8% | 0.0 | 
| aMe22 (L) | 1 | Glu | 20 | 2.8% | 0.0 | 
| Sm23 (L) | 10 | GABA | 20 | 2.8% | 0.6 | 
| MTe05 (L) | 7 | ACh | 17 | 2.3% | 0.7 | 
| aMe13 (L) | 1 | ACh | 16 | 2.2% | 0.0 | 
| CB1791 (L) | 2 | Glu | 13 | 1.8% | 0.8 | 
| SMP217 (L) | 3 | Glu | 12 | 1.7% | 0.6 | 
| SLP064 (L) | 1 | Glu | 11 | 1.5% | 0.0 | 
| Sm17 (L) | 4 | GABA | 7 | 1.0% | 0.5 | 
| SMP527 (L) | 1 | Unk | 6 | 0.8% | 0.0 | 
| CB2216 (L) | 1 | GABA | 4 | 0.6% | 0.0 | 
| cM08c (L) | 2 | Glu | 4 | 0.6% | 0.5 | 
| MeTu2b (L) | 3 | ACh | 4 | 0.6% | 0.4 | 
| MeTu2a (L) | 4 | ACh | 4 | 0.6% | 0.0 | 
| Sm30 (L) | 4 | GABA | 4 | 0.6% | 0.0 | 
| SLP076 (L) | 1 | Glu | 3 | 0.4% | 0.0 | 
| Lat (L) | 1 | Unk | 3 | 0.4% | 0.0 | 
| DNg30 (L) | 1 | 5-HT | 3 | 0.4% | 0.0 | 
| CL100 (L) | 1 | ACh | 3 | 0.4% | 0.0 | 
| CB2587 (L) | 1 | Glu | 3 | 0.4% | 0.0 | 
| cL10 (L) | 1 | Glu | 3 | 0.4% | 0.0 | 
| APDN3 (L) | 2 | Glu | 3 | 0.4% | 0.3 | 
| cM08a (L) | 2 | 5-HT | 3 | 0.4% | 0.3 | 
| MeMe_e01 (R) | 2 | Glu | 3 | 0.4% | 0.3 | 
| Sm18 (L) | 3 | GABA | 3 | 0.4% | 0.0 | 
| MeMe_e10 (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| DH31 (L) | 1 | Unk | 2 | 0.3% | 0.0 | 
| CB2648 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| SLP368 (R) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB0386 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| MeMe_e10 (R) | 1 | GABA | 2 | 0.3% | 0.0 | 
| CB3449 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| MTe21 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB3765 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| aMe4 (L) | 2 | ACh | 2 | 0.3% | 0.0 | 
| MeTu3a (L) | 2 | ACh | 2 | 0.3% | 0.0 | 
| Tm32 (L) | 2 | Glu | 2 | 0.3% | 0.0 | 
| aMe19a (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| aMe5 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| Sm10 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| MTe51 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| Sm04 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| LHPV5i1 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| Tm16 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MTe32 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| aMe9 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| MTe07 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| Tm1 (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| MeTu4b (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB2989 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| cM08b (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| Mi9 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| Tm5e (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| MTe47 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| MeMe_e04 (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| Sm16 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| aMe19b (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| MeMe_e08 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| Mi14 (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| T2a (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| Sm12 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| MeTu3b (L) | 1 | Unk | 1 | 0.1% | 0.0 | 
| Sm08 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| Sm07 (L) | 1 | GABA | 1 | 0.1% | 0.0 | 
| SLP211 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| aMe8 (L) | 1 | ACh | 1 | 0.1% | 0.0 | 
| CB1984 (L) | 1 | Glu | 1 | 0.1% | 0.0 | 
| CB3081 (L) | 1 | ACh | 1 | 0.1% | 0.0 |